• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.37 número1

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.37 número1"

Copied!
5
0
0

Texto

(1)

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

w w w . r b h h . o r g

Original

article

Association

between

maternal

and

fetal

factors

and

quality

of

cord

blood

as

a

source

of

stem

cells

Rodrigo

Dias

Nunes

,

Flávia

Maria

Zandavalli

UniversidadedoSuldeSantaCatarina(UNISUL),Florianópolis,SC,Brazil

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received16February2014 Accepted3July2014

Availableonline26November2014

Keywords:

Stemcells Fetalblood Transplantation

Cordbloodstemcelltransplantation Bloodbanks

a

b

s

t

r

a

c

t

Objectives:Tocomparativelyanalyzematernalandfetalfactorsandqualitymarkersofblood samplesinapublicumbilicalcordbloodbank.

Method:Thisisacross-sectionaldescriptivestudythatrevisited458recordsofdonations fromSeptember2009toMarch2013attheHemocentrodeSantaCatarina.Themeansof markerswereusedtodefinecutoffpointsforthequalityofcordblood.

Results:Mostdonationscamefromwomen withagesbetween18 and29years (62.8%), gestationalage≥40weeks(55.2%),vaginaldelivery(51.3%),primiparous(41.4%),andwith malenewborns(54.4%)weighingbetween3000and3499g(41.8%).Thevolumeofthe dona-tionsrangedfrom71.6to275.2mL,thetotalnucleatedcellcountrangedfrom4.77×108to

31.0×108cellsandCD34+cellsrangedfrom0.05to1.23%.Therewerestatisticallysignificant

differencesinthevolumewithrespecttogestationage>38weeks(p-value=0.001),cesarean section(p-value<0.001)andbirthweight>3500g(p-value<0.001).Thetotalnucleatedcell countwaspositivelyaffectedbycesareansection(p-value=0.022)andbirthweight>3500g (p-value<0.001).Therewasnostatisticallysignificantdifferencebetweenthevariablesand thepercentageofCD34+cells.

Conclusions:Deliveryrouteandbirthweightinfluencethevolumeofcordbloodandthetotal nucleatedcellcount.Gestationalageinfluencesonlythevolumeofcordblood.

©2014Associac¸ãoBrasileiradeHematologia,HemoterapiaeTerapiaCelular.Published byElsevierEditoraLtda.Allrightsreserved.

Introduction

Umbilicalcordblood,whichpreviouslyusedtobediscarded, canbecollectedshortlyafterbirthandhasgreatcapacityto reconstitutethehematopoieticsystem.1Severalstudieshave

shown the simplicityof umbilicalcordblood collection, in additiontothelackofriskforbothmotherandnewborn,low

Correspondingauthorat:Av.PedraBrancan25,CidadeUniversitáriaPedraBranca,88137-270Palhoc¸a,SC,Brazil.

E-mailaddress:rodrigo.dias.nunes@hotmail.com(R.D.Nunes).

riskofgraft-versus-hostdiseaseandlowriskoftransmitting infectious-contagiousdiseases.2,3Furthermore,itisauseful

alternativeofhematopoieticstemcellsfortransplantationto treatdiseasesoftheblood,immunesystemandforgenetic disorders.3,4

One of the limitations of this type of transplant is the volumeandcontentsofthebloodcollectedfromthe umbil-ical cord which is an obstacle to hematopoietic stem cell

http://dx.doi.org/10.1016/j.bjhh.2014.07.023

(2)

grafting.Themainparametersusedinumbilicalcordblood banksincludethetotalnucleatedcell(TNC)count,percentage ofCD34+cells,andthevolumeofblood.5

Transplantationsusingumbilicalcordbloodarestillinthe researchphaseandvariablesthatmightimprovethequalityof bloodarecurrentlythefocusofresearch,inasmuchas know-ingthesefactorsmayresultinlowercostsandlesswasteof timeintheevaluation,processingandstorageofmaterial.6,7

Recentstudiesreportthatsomevariablesaffectthequality oftheumbilicalcordblood,especiallythoserelatedto mater-nalandfetalfeaturessuchasplacentalweight,birthweight, gestationalage(GA),routeofdelivery,genderofthenewborn, amongotherthings;thusresearchisbeingdevelopedinthis areatoattempttoimprovecelllevels,whichisessentialto increasegraftingsuccessrates.

Objectives

Theaimsofthisstudyweretodeterminematernalandfetal characteristics of umbilical cord blood donors, to evaluate qualitymarkersofumbilicalcordblood,aswellasto deter-mineassociationsbetweenmaternalandfetalcharacteristics andthesequalitymarkers.

Methods

This is an observational, cross-sectional, epidemiological study that revisited 458 charts of patients who, between September2009andMarch2013,donatedumbilicalcordblood attheBloodUmbilicalCordandPlacentalBank(BSCUP)ofthe HemocentrodeSantaCatarina(HEMOSC),locatedinthecity ofSãoJosé,SantaCatarina.Ninemedicalrecordsofpatients whoperformedallogeneicdonationswereexcluded.Data col-lectionbeganafterthestudywasapprovedbytheResearch EthicsCommitteeofHEMOSC,anddatawerecollectedfrom computerizedregistersintheCryobiologySectorofHEMOSC, locatedinFlorianópolis,SantaCatarina.

Donationcandidatesweresubmittedtothestandard sur-veyofHEMOSCbeforecollectioninordertoassesspersonal history,familyhistory,and laboratoryresultswithstandard questionsusedforallkinds ofblood donation.Allpatients whoagreedtodonatesignedaninformedconsentformbefore thecollection.

Adatacollectioninstrumentwasdevelopedexclusivelyfor thisstudy whichinvestigatedthematernalage,gestational age,routeofdelivery,numberofpreviouspregnancies, gen-derandnewbornweight.Moreover,thepreprocessing(blood volume)andpost-processingdata(TNCandCD34+counts)of

theumbilicalcordbloodwerestudied.Themeansofmarkers wereusedtodefinecutoffpointsforthequalityofcordblood. Blood collection was performed extra-utero and carried outbyatrainedprofessionalinaseparateroom.Assoonas placental deliveryoccurs,the placenta istaken toan area reservedforcollection wheretheumbilical cordiscleaned withanantisepticsolutionandthebloodisdrainedbygravity throughthemostdistalpuncturesite.Thebloodisstoredin astandardbloodbag containingcitrate-phosphate-dextrose anticoagulant.

Oncecollected,thesesamplesarelabeledandsenttoblood banks, where theyundergo safety testing,HLAtyping and cryopreservation.Typically,collectionsarekeptforatimenot exceeding 24–28h at22±2◦C before processing, and then

cryopreserved inliquid nitrogen, under controlledfreezing ratesandstoredlongterminaccordancewithinternational criteriaatatemperaturelowerthan−150◦C.1,8,9The

umbil-ical cord blood was processed within a maximum of 48h afterbeingcollectedasisdeterminedbytheNationalHealth SurveillanceAgency(ANVISA).2

CollecteddatawerestoredintheMicrosoftExcelcomputer programandlaterexportedtotheStatisticalPackageforthe SocialSciences(Version16.0)foranalysis.

Qualitative variables aredescribed asabsoluteand rela-tivefrequencies,whilequantitativevariablesaredescribedas means±standarddeviations.

TheChi-squaredtest(2)orFisher’sexacttestwasused

totestthehomogeneityofproportions.Prevalenceratios(PR) and 95%confidenceintervals(95%CI)were calculated.The levelofsignificancewassetforap-value<0.05.

Results

Mostdonationscamefromwomenwithagesfrom18to29 years (62.8%) and from 30 to 34 years (24.4%), gestational age≥40weeks(55.2%),vaginaldelivery(51.3%),primiparous (41.4%),andwithmalenewborns(54.4%)weighingbetween 3000and3499g(41.8%).

Comparisonsbetweenmaternalandfetalcharacteristics andcordbloodvolumeareshowninTable1.

Statisticallysignificantdifferenceswerefoundinrespect to cord blood volume for gestational age>38 weeks (p -value=0.001), cesarean delivery (p-value<0.001) and birth weight>3500g(p-value<0.001).

A smallervolumeofumbilical cordblood wascollected whenthegestationalagewasbelow37weeksand6days com-paredwithgestationalagesbetween38and39weeksand6 days.Vaginalrouteofdeliverywasassociatedwithasmaller volumeofcordbloodwhencomparedtocesareandelivery. Newbornweightbetween2500and3499gwasassociatedwith lower volumeofumbilicalcordblood whencomparedwith infantsweighing4000–4999g.Theprevalenceoflowervolume wasapproximatelytwotimeshigherthanthereferencevalue. Thecomparisonbetweenmaternalandfetal characteris-ticsandTNCcountispresentedinTable2.

VaginalrouteofdeliverywasassociatedwithalowerTNC countthancesareandelivery.Birthweightsbetween2500and 3499gwere associatedwithlower TNCcountscomparedto thosebetween4000and4499g,whichwereatleast2.4times greater.

Therewerenostatisticallysignificantdifferencesbetween qualitymarkers–bloodvolume,TNCcountandpercentageof CD34+.

Discussion

(3)

Table1–Maternalandfetalcharacteristicsandcordbloodvolume.

Variable Volume(mL) p-Value PR(95%CI)

≤115.20 >115.20 Total

n(%) n(%) n(%)

GA 0.001

36to37/6weeks 24(92.3) 2(7.7) 26(6.0) 1.70(1.08–2.67)

38to39/6weeks 90(54.2) 76(45.8) 166(38.8) 1.0

≥40weeks 132(55.9) 104(44.1) 236(55.2) 1.03(0.79–1.35)

Deliveryroute <0.001

Cesarean 107(49.1) 111(50.9) 218(48.7) 1.0

Vaginal 151(65.7) 79(34.3) 230(51.3) 1.34(1.04–1.71)

Birthweight <0.001

2000–2499g 3(75.0) 1(25.0) 4(0.9) 2.39(0.69–8.20)

2500–2999g 46(88.5) 6(11.5) 52(11.6) 2.82(1.60–4.98)

3000–3499g 121(64.7) 66(35.3) 187(41.8) 2.06(1.22–3.47)

3500–3999g 71(49.3) 73(50.7) 144(32.1) 1.57(0.91–2.70)

4000–4499g 16(31.4) 35(68.6) 51(11.4) 1.0

≥4500g 1(10.0) 9(90.0) 10(2.2) 0.32(0.04–2.40)

GA:gestationalage;PR:prevalenceratio;95%CI:95%confidenceinterval.

forreconstitution.Thesecellsareessentialforthetreatment ofsomehematologicneoplasias.

Inthisanalysis,otherfactorsconsideredimportant,such asalcohol intakeand smoking during pregnancy were not studiedbecausethisinformationdidnotexistinthepatient’s records.

Inthisstudy,vaginalroutewas themostcommonform ofdelivery,similartothestudybyRosenauetal.4that

inves-tigated1549units ofumbilicalcordblood,ofwhich 75.27% were collected after vaginal delivery; again similar to this study52.03%ofthenewbornsweremale.4AccordingtoOmori

etal.,1069.8%ofthedonorswereprimiparous.Thisfactmight

indicateatendencyofyoungpeopletodonateumbilicalcord bloodasmostofthesewomenwereyoungand41.4%hadno otherchild. Thisprovestheimportanceoffurtherresearch involvingumbilicalcordbloodandthefactorsthatinfluence thequality.

Themean birth weightof the newborn, according to a retrospectiveanalysisbyMancinellietal.,11 was3390gand

thereforesimilartothisstudy.

Accordingtotheresults,thegestationalageonlypositively influenced thevolumeofblood;thegreater thegestational age, the larger the volume ofumbilical cord blood.Askari etal.,inordertodemonstratewhichvariablesaffectthethree mainqualityparametersofumbilicalcordblood,showedthat agestationalageofover40weekswasapredictorforalarger volumeofblood,similartothecurrentstudy.6Shu-HuiWen

etal.demonstratedthatgestationalagewasinversely propor-tionaltothevolume.4Alongwithincreasinggestationalage,

thereisaphysiologicalplacentalsenescence,especiallyfrom 36weeksofgestationonwards.Thisplacentalagingcreates areducedoxygensupplytothefetus,releasing vasoconstric-torsubstances that,onreachingthe placenta,couldreflect ina reducedblood volumeavailableforcollectionatbirth. Inthisstudynosignificantdifferenceswerefoundbetween gestationalageandotherqualityparameters(TNCandCD34+

cellcounts).However,someauthorsfoundapositive relation-shipbetweengestationalageandtheCD34+ cellcount.12–15

Thisinformationcastsdoubtonthehypothesisthat placen-tal aging andconsequent reductionin blood supplyto the

Table2–Maternalandfetalcharacteristicsandtotalnucleatedcellcount.

Variable TNCcount(×108cells) p-Value PR(95%CI)

≤9.33 >9.33 Total

n(%) n(%) n(%)

Deliveryroute(n=370) 0.022

Cesarean 85(44.0) 108(56.0) 193(52.2) 1

Vaginal 99(55.9) 78(44.1) 177(47.8) 1.27(1.03–1.56)

Birthweight(n=371) <0.001

2000–2499g 2(100) – 2(0.5) 4.08(0.91–18.24)

2500–2999g 25(80.6) 6(19.4) 31(8.4) 3.29(1.65–6.55)

3000–3499g 91(58.7) 64(41.3) 155(41.8) 2.40(1.31–4.38)

3500–3999g 54(43.2) 71(56.8) 125(33.7) 1.76(0.94–3.29)

4000–4499g 12(24.5) 37(75.5) 49(13.2) 1

≥4500g 1(11.1) 8(88.9) 9(2.4) 0.45(0.05–3.49)

(4)

fetuscouldprovidesmallernumbersofumbilicalcordblood hematopoieticcells.Someauthorsbelievethatwith advanc-inggestational ageand consequentlywith placentalaging, thefetus would becomeprogressivelyhypoxic, resulting in defensemechanisms. Thesemechanismswouldbe respon-siblefortheincreasesinthenumberofhematopoieticcellsin umbilicalcordblood.11

When the route of delivery was analyzed, it was seen thatcesareansectionwasassociatedwithhigherTNCcounts andgreaterbloodvolumes.Thisresulthasbeenreportedby severalstudies.5,11,13,14,16 However,other authorsassociated

vaginaldeliverywithhigherTNCcounts.4,5,17Onehypothesis

forcesareansectionsbeingresponsibleforagreatervolume ofblood collectedfrom theumbilicalcordbloodisthefact thatthe newbornisplacedabove the placentabefore cord clamping,possiblycausingadownwardflowofbloodintothe umbilicalcordandconsequentlyintotheplacental compart-ment.Anotherhypothesisisthatcesareandeliverypermitsa fastmanualextractionoftheplacentatherebyreducingthe chanceofbloodclotformation.11

As expected, the weight of the newborn at birth pre-sentedapositiverelationshipwithtwolaboratoryparameters analyzed:theTNCcountandbloodvolume.Inthisstudy, sig-nificantly higherTNCcountsand volumeswere associated withbirthweightsabove3500g.Toreinforcethesefindings, other studies reported that greater birth weight positively influenced these parameters.5,11,12,17,18 Mancinelli et al., in

ordertodeterminewhichobstetricsfactorsinfluencethe qual-ityofumbilicalcordblood,showedthatahigherbirthweight wasassociatedwithbetterqualityofumbilicalcordbloodin relationtothethreemainvariables:TNCandCD34+ counts

and the blood volume.11 Other authors also reported that

thisfactorwasassociatedwithincreasedCD34+counts4,13,19;

thiswasnotconfirmedinthecurrentstudy.Thusthegreater birthweight,withaconsequentincreaseinplacentalvolume, somehowleadstoincreasedblood volumeinthe placenta. However,unlikethe resultsintheliterature,thisreasoning doesnotexplainthe correlationbetweenplacentalvolume accordingtobirthweightandthenumberofCD34+cells.

Possibly,thedeterminantofthequalityofthestemcells willbedefinedaftertheir use inpatientsand willthus be evaluatedintheclinicalpractice.Theincreasing applicabil-ityanddevelopmentoftechnologyshouldservetohighlight theresultsfoundinthisstudyandinmanyotherstudiesthat dealwiththissubject.

Conclusions

Agestationalagegreaterthanorequalto38weeks,cesarean deliveryandbirthweightgreaterthanorequalto3500g posi-tivelyinfluencethebloodvolumecollectedfromtheumbilical cord.Cesareandeliveryandbirthweightgreaterthanorequal to3500galsohavepositivecorrelationswiththeTNCcount. Noneofthematernal-fetalcharacteristicsinterferewiththe CD34+cellcount.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1.ArmsonBA.Umbilicalcordbloodbanking:implicationsfor perinatalcareproviders.JObstetGynaecolCan.

2005;27(3):263–90.

2.BariniR,FerrazUC,AcácioGL,MachadoIN.Doesthetime betweencollectingandprocessingumbilicalcordblood samplesaffectthequalityofthesample?Einstein.2011;92Pt 1:207–11.

3.GomesTL,PrankeP.Comparac¸ãoentreascélulas-troncode sanguedecordãoumbilicaldeneonatosprematurose nascidosatermo:umarevisão.RBAC.2008;40(1): 25–30.

4.WenSH,ZhaoWL,LinPY,YangKL.Associationsamongbirth weight,placentalweight,gestationalperiodandproduct qualityindicatorsofumbilicalcordbloodunits.Transfus ApherSci.2012;46(1):39–45.

5.JanRH,WenSH,ShyrMH,ChiangBR.Impactofmaternaland neonatalfactorsonCD34+cellcount,totalnucleatedcells, andvolumeofcordblood.PediatrTransplant.

2008;12(8):868–73.

6.AskariS,MillerJ,ChryslerG,McCulloughJ.Impactofdonor andcollection-relatedvariablesonproductqualityinexutero cordbloodbanking.Transfusion.2005;45(2):

189–94.

7.RosenauE,SugrueM,HallerM,FiskD,KellySS,ChangM, etal.Characteristicsofthawedautologousumbilicalcord blood.Transfusion.2012;52(10):2234–42.

8.PedrassaP,HamerschlakN.Transplantedecélulas-troncode sanguedocordãoumbilical.PratHosp.2008;55:

98–102.

9.ColdwellK,LeeS,KeanJ,KhooCP,TsaknakisG,SmytheJ, etal.Effectsofobstetricfactorsandstoragetemperatureson theyieldofendothelialcolonyformingcellsfromumbilical cordblood.Angiogenesis.2011;14(3):81–92.

10.OmoriA,HiraiM,ChibaT,TakahashiK,YamaguchiS, TakahashiTA,etal.Quality-assessmentsofcharacteristicsof placental/umbilicalcordbloodassociatedwithmaternal age-andparity-relatedfactor.TransfusApherSci.2012;46(1): 7–13.

11.MancinelliF,TamburiniA,SpagnoliA,MalerbaC,SuppoG, LasorellaR,etal.Optimizingumbilicalcordbloodcollection: impactofobstetricfactorsversusqualityofcordbloodunits. TransplantProc.2006;38(4):1174–6.

12.NakagawaR,WatanabeT,KawanoY,KanaiS,SuzuyaH, KanekoM,etal.Analysisofmaternalandneonatalfactors thatinfluencethenucleatedandCD34+cellyieldforcord bloodbanking.Transfusion.2004;44(2):262–7.

13.WuJY,LiaoC,ChenJS,XuZP,GuSL,WuSQ,etal.Analysisof maternalandneonatalfactorsassociatedwithhematopoietic reconstructionpotentialinumbilicalcordbloodunits. ZhongguoShiYanXueYeXueZaZhi.2010;18(6): 1535–41.

14.YamadaT,OkamotoY,KasamatsuH,HorieY,YamashitaN, MatsumotoK.Factorsaffectingthevolumeofumbilicalcord bloodcollections.ActaObstetGynecolScand.

2000;79(10):830–3.

15.AtanassovaV,AtanassovaM,NikolovA,ZlatkovV,

MihaylovaA,NaumovaE.Influenceofobstetricfactorsonthe qualityofcordbloodunitscollectedforallogeneic

transplantation.AkushGinekol(Sofiia).2012;51(2):11–6.

16.SparrowRL,CauchiJA,RamadiLT,WaughCM,KirklandMA. InfluenceofmodeofbirthandcollectiononWBCyieldsof umbilicalcordbloodunits.Transfusion.2002;42(2):210–5.

(5)

18.KeersmaekersCL,MasonBA,KeersmaekersJ,PonziniM, MlynarekRA.Factorsaffectingumbilicalcordbloodstemcell suitabilityfortransplantationinaninuterocollection program.Transfusion.2014;54(3):545–9.

Imagem

Table 2 – Maternal and fetal characteristics and total nucleated cell count.

Referências

Documentos relacionados

Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department. Clark OA, Lyman GH, Castro AA, Clark LG,

Age, gender, Durie–Salmon stage, history of autologous hematopoietic stem cell transplantation, and the distribution pattern and positivity of CD20 expression on multiple myeloma

This study demonstrates that 18.6% of a representative sam- ple of community-dwelling elderly people from São José dos Campos, southeastern Brazil had mild anemia with the

Single nucleotide polymorphism array analysis increased the detection rate of abnormalities compared to karyotyping and also identified a new set of abnormalities that deserve

On admission, the patient’s bone marrow was reexamined and the cytogenetic analysis showed Philadelphia chromosomes in all of the metaphases analyzed; this result was confirmed by

standard operating procedures for all steps in the transfusion process; (f) training all hospital staff involved in transfusion; (g) monitoring the usage of blood and blood

Using chronic myeloid leukemia as an integration theme, students learn about cell dynamics, including structural and biochemical aspects of cell components, such as

Are the review criteria for automated complete blood counts of the International Society of laboratory Hematology suitable for all